Pomelo Care secures $92M to revolutionize maternal and pediatric healthcare

Pomelo Care has raised $92 million in a Series C funding round led by Stripes. The investment pushes the company’s valuation to $1.7 billion. The platform specialises in proactive, data-driven healthcare for women and children, aiming to cut costs while improving outcomes. The new funding will help Pomelo Care grow its partnerships with health plans and employers across the US. Expansion plans also include broader services in reproductive care, pregnancy, paediatrics, and hormonal health.

The company’s platform uses data science and a team of specialists to spot early health risks. Clinicians then deliver tailored care through 24/7 support, guided by patient insights and evidence-based protocols. Pomelo’s approach targets reductions in preterm births, NICU admissions, and overall medical expenses. By combining technology with clinical expertise, the company seeks to make high-quality care more accessible. The goal is to lower costs for patients while ensuring better health results for mothers and children.

With $92 million in fresh capital, Pomelo Care will scale its operations and refine its care model. The investment will fund wider adoption of its platform among insurers and businesses. The company’s focus remains on measurable improvements in maternal and child health outcomes.